FindTrial
Sign In

A study of T lymphocyte subsets in children with systemic lupus erythematosus

A study of T lymphocyte subsets in children with systemic lupus erythematosus

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000038519
Enrollment
Unknown
Registered
2020-09-23
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

systemic lupus erythematosus in children

Interventions

Gold Standard:anti-nuclear antibodies
Index test:WBC,&#32
CD4+T&#32
cells,&#32
CD4+CCR7+CD95+T&#32
CD4+CD45RA-CCR7+T&#32
CD4+CD45RA-CCR7-Tcells

Sponsors

Tianjin Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 17 Years

Inclusion criteria

Inclusion criteria: 1. children aged less than 18 years old; 2. systemic lupus erythematosus patients who fulfilled the Systemic Lupus International Collaborating Clinics(SLICC-2012)classification criteria.

Exclusion criteria

Exclusion criteria: SLE patients who had been treated by biological agents

Design outcomes

Primary

MeasureTime frame
WBC;CD4+T cells;CD4+CCR7+CD95+T cells;CD4+CD45RA-CCR7+T cells;CD4+CD45RA-CCR7-T cells;—

Countries

China

Contacts

Public ContactJing Yin

Tianjin Children's Hospital

yinjingemail@163.com+86 13652178808

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026